Skip to main content
. 2021 May 17;35(10):2936–2947. doi: 10.1038/s41375-021-01275-5

Fig. 8. Graphical summary.

Fig. 8

High GDF-11 levels in the MDS BMME activate Smad2/3 phosphorylation and expression of Co-Smad4 that binds to the SDF-1 promoter region [7] thereby suppressing transcription and leading to impaired hematopoiesis. Trapping GDF-11 by RAP-536/luspatercept reduces Smad2/3 and Smad4 activity resulting in SDF-1 promoter activation and elevated expression, thereby restoring HSPC support.